Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response.

Abstract:

:Gene therapy for heart diseases requires availability of an efficient vector for gene transfer into myocardium. Recombinant adenovirus expressing the Escherichia coli beta-galactosidase (beta-Gal) gene was shown to infect rat cardiocytes efficiently in vivo. However, a time course of gene expression showed that transgene expression was maximal during the first week following injection, then declined and disappeared by day 21. An immunosuppressive treatment prolonged beta-Gal expression for at least 21 days. On the contrary, a preimmunization of the animals by two intraperitoneal injections of the vector led to a decreased transgene expression 48 hr after intramyocardial injection and to a barely detectable expression at the sixth day. Appearance of adenovirus neutralizing antibodies in preimmunized animals could have contributed to such a refractoriness to further adenoviral infection. Finally, a neonatal intrathymic injection of the vector was able to induce long-term LacZ expression for more than 2 months after heart injection, although neutralizing as well as anti-beta-Gal antibodies were detected in sera of the animals. These results indicate that an immune response against first-generation replication-defective adenoviral vectors is a major cause of transient transgene expression, a cellular response being most probably responsible for ablation of transgene expression in immunocompetent animals.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Gilgenkrantz H,Duboc D,Juillard V,Couton D,Pavirani A,Guillet JG,Briand P,Kahn A

doi

10.1089/hum.1995.6.10-1265

subject

Has Abstract

pub_date

1995-10-01 00:00:00

pages

1265-74

issue

10

eissn

1043-0342

issn

1557-7422

journal_volume

6

pub_type

杂志文章
  • Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases.

    abstract::Administration of plasmid/lipid complexes to the lung airways for the treatment of metastatic pulmonary diseases represents a new strategy of gene therapy. In this study we present evidence that intratracheal administration of a plasmid encoding murine IL-12 complexed with N-[1-(2,3-dioleyloxy)propyl)-N,N,N-trimethyla...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950018481

    authors: Blezinger P,Freimark BD,Matar M,Wilson E,Singhal A,Min W,Nordstrom JL,Pericle F

    更新日期:1999-03-20 00:00:00

  • Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells.

    abstract::Development of multidrug resistance (MDR) is the major obstacle to successful cancer chemotherapy. We have developed Daudi human lymphoma cells that are 20-fold more resistant than the parent cell line to vincristine (VCR) by infecting cells with pHaMDR1/A retroviral vector (Daudi/MDR20). Three DNA sequences of anti-M...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950018175

    authors: Wang FS,Kobayashi H,Liang KW,Holland JF,Ohnuma T

    更新日期:1999-05-01 00:00:00

  • Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease.

    abstract::Huntington's disease (HD) is a fatal neurodegenerative disease caused by a genetic expansion of the CAG repeat region in the huntingtin (HTT) gene. Studies in HD mouse models have shown that artificial miRNAs can reduce mutant HTT, but evidence for their effectiveness and safety in larger animals is lacking. HD transg...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2017.199

    authors: Pfister EL,DiNardo N,Mondo E,Borel F,Conroy F,Fraser C,Gernoux G,Han X,Hu D,Johnson E,Kennington L,Liu P,Reid SJ,Sapp E,Vodicka P,Kuchel T,Morton AJ,Howland D,Moser R,Sena-Esteves M,Gao G,Mueller C,DiFiglia M

    更新日期:2018-06-01 00:00:00

  • Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium.

    abstract::The influence of serum on the production of retroviral vectors by the HT1080 human fibrosarcoma-derived packaging cell line FLYRD18 was investigated. A fourfold increase in virus titer was observed under serum-free conditions, as compared with medium supplemented with 10% fetal calf serum. A similar improvement was al...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950017329

    authors: Gerin PA,Gilligan MG,Searle PF,Al-Rubeai M

    更新日期:1999-08-10 00:00:00

  • Maternal Therapy with Ad.VEGF-A165 Increases Fetal Weight at Term in a Guinea-Pig Model of Fetal Growth Restriction.

    abstract::In a model of growth-restricted sheep pregnancy, it was previously demonstrated that transient uterine artery VEGF overexpression can improve fetal growth. This approach was tested in guinea-pig pregnancies, where placental physiology is more similar to humans. Fetal growth restriction (FGR) was attained through peri-...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2016.046

    authors: Swanson AM,Rossi CA,Ofir K,Mehta V,Boyd M,Barker H,Ledwozyw A,Vaughan O,Martin J,Zachary I,Sebire N,Peebles DM,David AL

    更新日期:2016-12-01 00:00:00

  • Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells.

    abstract::The inherited deficiency in adenosine deaminase (ADA), which results in severe combined immunodeficiency, is generally regarded as an optimal model for the development of human somatic gene therapy. The ideal target for the correction of ADA deficiency and other lympho-hematopoietic disorders would be the hematopoieti...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1991.2.3-203

    authors: Cournoyer D,Scarpa M,Mitani K,Moore KA,Markowitz D,Bank A,Belmont JW,Caskey CT

    更新日期:1991-10-01 00:00:00

  • Upregulation of Bag-1 by ex vivo gene transfer protects rat livers from ischemia/reperfusion injury.

    abstract::Bag-1 exerts powerful antiapoptotic effects by binding and stabilizing Bcl-2 and interacting with the tumor necrosis factor receptor type I-induced death signal. We examined the effects of overexpression of Bag-1 by ex vivo adenoviral gene transfer on cold (4 degrees C for 24 hr) ischemia/reperfusion (I/R) injury of r...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340260185120

    authors: Sawitzki B,Amersi F,Ritter T,Fisser M,Shen XD,Ke B,Busuttil R,Volk HD,Kupiec-Weglinski JW

    更新日期:2002-08-10 00:00:00

  • Antisense oligonucleotides for the treatment of spinal muscular atrophy.

    abstract::Spinal muscular atrophy (SMA) is an autosomal recessive disease affecting ∼1 in 10,000 live births. The most striking component is the loss of α-motor neurons in the ventral horn of the spinal cord, resulting in progressive paralysis and eventually premature death. There is no current treatment paradigm other than sup...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2012.225

    authors: Porensky PN,Burghes AH

    更新日期:2013-05-01 00:00:00

  • Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancer.

    abstract::The purpose of this study was to assess the therapeutic potential of injecting the gene for HLA-B7/beta2-microglobulin into the subcutaneous metastatic nodules of patients who are refractory to conventional treatments. The nine patients evaluated were divided into three groups and given escalating doses of DNA (20, 40...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.14-2031

    authors: Heo DS,Yoon SJ,Kim WS,Lee KH,Seol JG,Lee SG,Jung CW,Cho EK,Kim CW,Park MH,Sung MW,Kim KH,Bang YJ,Kim NK

    更新日期:1998-09-20 00:00:00

  • Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis.

    abstract::Autoimmune destruction of islets in the pancreas leads to the development of insulin-dependent diabetes mellitus (IDDM). Replacement of insulin-producing tissue by transplantation of islets provides a cure to disease but requires immunosuppression or a means of controlling anti-graft immune responses. To promote islet...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.18-2717

    authors: Gallichan WS,Kafri T,Krahl T,Verma IM,Sarvetnick N

    更新日期:1998-12-10 00:00:00

  • Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression.

    abstract::Therapeutic levels of expression of the beta-globin gene have been difficult to achieve with conventional retroviral vectors without the inclusion of DNase I-hypersensitive site (HS2, HS3, and HS4) enhancer elements. We generated recombinant adeno-associated viral (AAV) vectors carrying an antisickling human beta-glob...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2007.173

    authors: Maina N,Zhong L,Li X,Zhao W,Han Z,Bischof D,Aslanidi G,Zolotukhin S,Weigel-Van Aken KA,Rivers AE,Slayton WB,Yoder MC,Srivastava A

    更新日期:2008-04-01 00:00:00

  • Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted hearts.

    abstract::The ability to control proliferation of grafted cells in the heart and consequent graft size could dramatically improve the efficacy of cell therapies for cardiac repair. To achieve targeted graft cell proliferation, we created a chimeric receptor (F36Vfgfr-1) composed of a modified FK506-binding protein (F36V) fused ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.161

    authors: Stevens KR,Rolle MW,Minami E,Ueno S,Nourse MB,Virag JI,Reinecke H,Murry CE

    更新日期:2007-05-01 00:00:00

  • Uptake, biodistribution, and time course of naked plasmid DNA trafficking after intratumoral in vivo jet injection.

    abstract::Nonviral jet injection is an applicable technology for in vivo gene transfer of naked DNA. However, little is known about the biodistribution and clearance of jet-injected DNA, or about its localization within tissue and cells. Therefore, in this study we analyzed the intratumoral and systemic biodistribution of jet-i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.17.611

    authors: Walther W,Minow T,Martin R,Fichtner I,Schlag PM,Stein U

    更新日期:2006-06-01 00:00:00

  • Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type II.

    abstract::Glycogen storage disease type II (GSDII) is a lysosomal storage disease caused by a deficiency in acid alpha-glucosidase (GAA), and leads to cardiorespiratory failure by the age of 2 years. In this study, we investigate the impact of anti-GAA antibody formation on cross-correction of the heart, diaphragm, and hind-lim...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2005.16.68

    authors: Cresawn KO,Fraites TJ,Wasserfall C,Atkinson M,Lewis M,Porvasnik S,Liu C,Mah C,Byrne BJ

    更新日期:2005-01-01 00:00:00

  • Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells.

    abstract::Cell encapsulation offers a safe and manufacturable method for the systemic delivery of therapeutic proteins from genetically engineered cells. However, control of dose delivery remains a major issue with regard to clinical application. We generated populations of immortalized murine NIH 3T3 fibroblasts that secrete m...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950018823

    authors: Serguera C,Bohl D,Rolland E,Prevost P,Heard JM

    更新日期:1999-02-10 00:00:00

  • Gene transfer into fetal baboon hematopoietic progenitor cells.

    abstract::We studied hematopoietic progenitors from fetal baboon blood, marrow, and liver at four time points (125, 140, 160, and 175 days) during the third trimester (gestation approximately 180 days) to determine if fetal baboons might be an appropriate model for in utero gene therapy of hematopoietic stem cells (HSCs). Cells...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950018742

    authors: Winkler A,Kiem HP,Shields LE,Sun QH,Andrews RG

    更新日期:1999-03-01 00:00:00

  • Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells.

    abstract::Hematopoietic stem cells (HSCs) are a potential target for the retrovirus-mediated transfer of chemotherapeutic drug resistance genes. For integration of the proviral DNA in the HSC genome cell division is required. In the bone marrow (BM) hematopoiesis occurs in the vicinity of stroma cells. Soluble stroma components...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950017789

    authors: Schiedlmeier B,Buss EC,Veldwijk MR,Zeller WJ,Fruehauf S

    更新日期:1999-06-10 00:00:00

  • Polyploidization without mitosis improves in vivo liver transduction with lentiviral vectors.

    abstract::Lentiviral vectors are efficient gene delivery vehicles for therapeutic and research applications. In contrast to oncoretroviral vectors, they are able to infect most nonproliferating cells. In the liver, induction of cell proliferation dramatically improved hepatocyte transduction using all types of retroviral vector...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2011.227

    authors: Pichard V,Couton D,Desdouets C,Ferry N

    更新日期:2013-02-01 00:00:00

  • Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses.

    abstract::Umbilical cord blood (CB) from the early gestational human fetus is recognized as a rich source of hematopoietic stem cells. To examine the value of fetal CB for gene therapy of inborn immunohematopoietic disorders, we tested the feasibility of genetic modification of CD34(+) cells from CB at weeks 24 to 34 of pregnan...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340150504000

    authors: Luther-Wyrsch A,Costello E,Thali M,Buetti E,Nissen C,Surbek D,Holzgreve W,Gratwohl A,Tichelli A,Wodnar-Filipowicz A

    更新日期:2001-03-01 00:00:00

  • High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation.

    abstract::We report a novel method for targeting adenovirus-mediated gene delivery. By irradiating mammalian cells prior to adenoviral transduction, adenoviral gene transfer is greatly improved and the adenoviral genome integrates into cellular DNA. In this work, human and rodent cell lines were irradiated and subsequently tran...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1997.8.9-1025

    authors: Zeng M,Cerniglia GJ,Eck SL,Stevens CW

    更新日期:1997-06-10 00:00:00

  • Aerosol delivery of a beta-galactosidase adenoviral vector to the lungs of rodents.

    abstract::Aerosol delivery of adenoviral vectors is of particular interest in regard to gene therapy for cystic fibrosis (CF), with potential advantages of more uniform respiratory delivery, a less invasive approach, and ease of repetition. The AdHCMVsp1LacZ (AdLacZ) adenoviral vector was used to evaluate the feasibility of aer...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1995.6.8-985

    authors: Katkin JP,Gilbert BE,Langston C,French K,Beaudet AL

    更新日期:1995-08-01 00:00:00

  • Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes).

    abstract::Deoxyribozymes, or DNA enzymes (DNAzymes), are novel nucleic acids that have the ability to bind to specific sequences of RNA, and to cleave the target site catalytically. DNAzymes are smaller and more efficient enzymatically than ribozymes (RZs), which are catalytic nucleic acids synthesized from ribonucleotides. We ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950016573

    authors: Wu Y,Yu L,McMahon R,Rossi JJ,Forman SJ,Snyder DS

    更新日期:1999-11-20 00:00:00

  • Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1.

    abstract::Adult T cell leukemia/lymphoma (ATL) is derived from CD4+ T cells and has a poor prognosis because of its resistance to chemotherapy. To evaluate the effectiveness of gene therapy for ATL, the effect of ganciclovir on ATL cell lines transfected with the thymidine kinase gene of herpes simplex virus type 1 (HSV-TK) was...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.18-2203

    authors: Obaru K,Fujii S,Matsushita S,Shimada T,Takatsuki K

    更新日期:1996-12-01 00:00:00

  • Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect.

    abstract::Duchenne muscular dystrophy (DMD) typically occurs as a result of truncating mutations in the DMD gene that result in a lack of expression of the dystrophin protein in muscle fibers. Various therapies under development are directed toward restoring dystrophin expression at the subsarcolemmal membrane, including gene t...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2013.092

    authors: Flanigan KM,Campbell K,Viollet L,Wang W,Gomez AM,Walker CM,Mendell JR

    更新日期:2013-09-01 00:00:00

  • The epidermis as a bioreactor: topically regulated cutaneous delivery into the circulation.

    abstract::Previous studies have documented that the skin can be used as a bioreactor to produce proteins for systemic release to treat diseases. A gene-switch system has been developed that allows regulated expression of therapeutic genes. To determine whether this system could be used in the skin, we developed a transgenic mou...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303402753812476

    authors: Cao T,Tsai SY,O'Malley BW,Wang XJ,Roop DR

    更新日期:2002-06-10 00:00:00

  • Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation.

    abstract::Janus kinase 3 (JAK3) is an essential component of cytokine receptor signal transduction pathways required for normal lymphocyte development and function. JAK3 deficiency in both mice and humans results in severe combined immunodeficiency (SCID) and increased susceptibility to opportunistic infections. We have previou...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303400750038462

    authors: Bunting KD,Lu T,Kelly PF,Sorrentino BP

    更新日期:2000-11-20 00:00:00

  • Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.

    abstract::NKG2D ligands (NKG2DLs) are widely expressed on ovarian cancers to various degrees, making them attractive targets for immunotherapy. Here, we applied a chimeric antigen receptor (CAR) approach for the targeting of NKG2DLs expressed on human ovarian cancer cells and evaluated the impact of pharmacological upregulation...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2012.143

    authors: Song DG,Ye Q,Santoro S,Fang C,Best A,Powell DJ Jr

    更新日期:2013-03-01 00:00:00

  • Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy.

    abstract::Recombinant adeno-associated virus serotype 2 (rAAV2)-based human gene therapy for cystic fibrosis has progressed through a series of preclinical studies and phase I and II clinical trials. This agent has shown an encouraging safety profile, consistent levels of DNA transfer, and positive evidence of short-term clinic...

    journal_title:Human gene therapy

    pub_type: 临床试验,杂志文章

    doi:10.1089/hum.2005.16.921

    authors: Flotte TR,Schwiebert EM,Zeitlin PL,Carter BJ,Guggino WB

    更新日期:2005-08-01 00:00:00

  • Poor expression of MDR1 transgene in HeLa cells by bicistronic Moloney murine leukemia virus-based vector.

    abstract::Cotransfer of a therapeutic gene together with the human MDR1 gene provides an opportunity to increase the number of transduced marrow cells, expressing the therapeutic gene, by in vivo selection for MDR1. We have used an Lg-MDR1-IRES-neo (LgMIN) retroviral vector, containing MDR1 and neo genes, separated by the EMCV ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.15-2263

    authors: Zaboikin MM,Schuening FG

    更新日期:1998-10-10 00:00:00

  • Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral delivery.

    abstract::Duchenne muscular dystrophy (DMD) is a lethal genetic disorder for which there is currently no effective treatment. Although clinical application of adenoviral vector-mediated gene transfer has not been fully developed, it shows promise for the treatment of DMD. One significant problem posed by adenoviral vector-media...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1995.6.11-1477

    authors: Clemens PR,Krause TL,Chan S,Korb KE,Graham FL,Caskey CT

    更新日期:1995-11-01 00:00:00